FREE Account Opening + No Clearing Fees
Loading...

Innokaiz India IPO vs Remus Pharmaceuticals IPO

Comparision between Innokaiz India IPO and Remus Pharmaceuticals IPO.

IPO Details

Innokaiz India IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Innokaiz India IPO Remus Pharmaceuticals IPO
Logo Innokaiz India IPO Logo Remus Pharmaceuticals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Gretex Corporate Services Limited Beeline Capital Advisors Pvt Ltd
Registrar Bigshare Services Pvt Ltd Link Intime India Private Ltd
Market Maker Gretex Share Broking Private Limited Sunflower Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Innokaiz India IPO is up to ₹21.17 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Innokaiz India IPO is ₹78.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

  Innokaiz India IPO Remus Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹76.00 per share ₹1,150.00 per share
Issue Price (Upper) ₹78.00 per share ₹1,229.00 per share
Issue Price (Final) ₹78.00 per share ₹1,229.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 100 shares
Fresh Issue Size 27,13,600 shares 3,88,000 shares
Fresh Issue Size (Amount) up to ₹21.17 Cr up to ₹47.69 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 27,13,600 shares 3,88,000 shares
Issue Size Total (Amount) up to ₹21.17 Cr up to ₹47.69 Cr

IPO Timetable

Innokaiz India IPO opens on Apr 28, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Innokaiz India IPO and Remus Pharmaceuticals IPO is May 03, 2023, and May 19, 2023, respectively.

  Innokaiz India IPO Remus Pharmaceuticals IPO
Anchor Bid Date Apr 27, 2023 May 16, 2023
Issue Open Apr 28, 2023 May 17, 2023
Issue Close May 03, 2023 May 19, 2023
Basis Of Allotment (Tentative) May 08, 2023 May 24, 2023
Initiation of Refunds (Tentative) May 09, 2023 May 25, 2023
Credit of Share (Tentative) May 10, 2023 May 26, 2023
Listing date (Tentative) May 11, 2023 May 29, 2023
Anchor Lockin End date 1 Jun 07, 2023 Jun 23, 2023
Anchor Lockin End date 2 Aug 06, 2023 Aug 22, 2023

Financials

Innokaiz India IPO P/E ratio is , as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

  Innokaiz India IPO Remus Pharmaceuticals IPO
Financial
Innokaiz India Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-202,568.3813,872.44361.55541.93540.93110.60
31-Mar-213,871.0718,506.21509.151,051.091,050.09103.52
31-Mar-224,972.4728,609.09791.631,842.721,841.72132.17
31-Oct-224,763.1514,883.52610.282,453.001,702.0093.62
Amount in ₹ Lakhs
Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20530.361,276.8981.16202.03201.0335.93
31-Mar-211,104.961,922.45102.58304.61303.6127.89
31-Mar-221,590.932,543.71338.57643.17543.1719.17
31-Dec-223,352.963,361.20643.901,712.071,603.57947.45
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 98.00 92.82%
Promoter Shareholding (Post-Issue) 71.99 68.37%
P/E Ratio 21.09
Market Cap ₹181.03 Cr.
ROE 71.44%%
ROCE 69.99%%
Debt/Equity 0.03
EPS ₹33.86
RoNW 52.64%%

Shares Offered

In the Innokaiz India IPO retail investors (RII) are offered 9,02,400 shares while in Remus Pharmaceuticals IPO retail investors are offered 9,02,400 shares. Qualified institutional buyers (QIB) are offered 5,15,200 shares in Innokaiz India IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.

  Innokaiz India IPO Remus Pharmaceuticals IPO
Anchor Investor Reserveration 7,72,800 shares 1,10,500 shares
Market Maker Reserveration 1,36,000 shares 19,500 shares
QIB 5,15,200 shares 1,38,750 shares
NII 3,87,200 shares 41,625 shares
RII 9,02,400 shares 97,125 shares
Employee 0 shares 0 shares
Others
Total 18,04,800 shares 2,77,500 shares

Bids Received (Subscription)

Innokaiz India IPO subscribed 95.08x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

  Innokaiz India IPO Remus Pharmaceuticals IPO
QIB (times) 23.93x 10.75x
NII (times) 303.92x 229.31x
Big NII (times)
Small NII (times)
RII (times) 46.10x 49.81x
Employee (times)
Other (times)
Total (times) 95.08x 57.21x

Comments

Add a public comment...